How the Clinical Oncology Next Generation Sequencing Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Industry-Specific Factors Are Fueling the Growth of theClinical Oncology Next Generation Sequencing Market?
The rising incidence of cancer globally is anticipated to contribute to the growth of the clinical oncology next-generation sequencing market. For instance, the National Cancer Institute (NCI) reported that there were 18.1 million cancer survivors in the U.S. in May 2024, a number expected to increase to 22.5 million by 2032. By 2040, it is projected that new cancer cases will reach 29.9 million annually, with cancer-related deaths rising to 15.3 million. As a result, the increasing cancer incidence is expected to drive demand for clinical oncology next-generation sequencing technologies.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp
#What Growth Opportunities Will Drive the Clinical Oncology Next Generation Sequencing Market’s CAGR Through 2034?
The clinical oncology next generation sequencing market has expanded rapidly in recent years. It is projected to grow from $0.51 billion in 2024 to $0.58 billion in 2025, at a CAGR of 14.8%. This growth has been driven by progress in genomic research, discovery of cancer biomarkers, advancements in sequencing technologies, and regulatory clearances.
The clinical oncology next-generation sequencing market is set for rapid growth, reaching $0.95 billion by 2029 at a CAGR of 12.9%. This growth is driven by increasing cancer incidence and advancements in precision medicine. Trends include comprehensive genomic profiling (CGP), tumor evolution research, and AI-powered tools.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3344
What Key Market Trends and Innovations Are Shaping the Future of theClinical Oncology Next Generation Sequencing Industry?
In the clinical oncology next-generation sequencing market, firms are launching advanced diagnostic tools like the BenchMark ULTRA PLUS system. Released in June 2022 by Roche, this system enhances accuracy and speed in tissue staining for cancer diagnostics, supporting timely and informed treatment decisions in clinical labs.
Which Companies Are Leading the Charge in Expanding theClinical Oncology Next Generation Sequencing Market Growth?
Major companies operating in the clinical oncology next generation sequencing market include Thermo Fisher Scientific, Oxford Nanopore Technologies Ltd., QIAGEN N.V., Myriad Genetics Inc., Illumina Inc., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Agilent Technologies Inc., Pacific Biosciences of California Inc., Caris Life Sciences, Paradigm Diagnostics, GATC Biotech AG, Macrogen Inc., DNASTAR Inc., Exosome Diagnostics Inc., Biomatters Ltd., Partek Inc., Foundation Medicine Inc., Becton Dickinson and Company (BD), Takara Bio Inc., Creative Biolabs, Mogene LC, Knome Inc., Genomatix Software GmbH, CLC bio, GnuBIO Inc., Bio-Rad Laboratories Inc., BGI Genomics Co. Ltd., Guardant Health Inc., Invitae Corporation, Natera Inc., NeoGenomics Laboratories Inc., Sysmex Corporation, Veracyte Inc., Zymo Research Corporation, ArcherDX Inc., Cepheid, Karius Inc., OncoDNA S.A., Personal Genome Diagnostics Inc., PierianDx Inc.
Order Your Report Now For A Swift Delivery:
How is the Global Clinical Oncology Next Generation Sequencing Market Segemented?
The clinical oncology next generation sequencing market covered in this report is segmented –
1) By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing
2) By Application: Screening, Companion Diagnostics, Other Diagnostics
3) By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic Laboratories
Subsegments:
1) By Ion Semiconductor Sequencing: Ion Proton System, Ion PGM System, Ion S5 System, Other Ion Semiconductor Sequencing Technologies
2) By Pyro-Sequencing: 454 Pyrosequencing, Other Pyro-Sequencing Technologies
3) By Synthesis Sequencing: Illumina Sequencing Technology, SOLiD Sequencing Technology, Other Synthesis Sequencing Technologies
4) By Real-Time Sequencing: PacBio RS II System, Sequel System, Other Real-Time Sequencing Technologies
5) By Ligation Sequencing: Helicos Single Molecule Sequencing, Other Ligation Sequencing Technologies
6) By Reversible Dye Termination Sequencing: Illumina HiSeq, Illumina NextSeq, Other Reversible Dye Termination Sequencing Technologies
7) By Nano-Pore Sequencing: Oxford Nanopore Technologies (MinION, GridION, PromethION), Other Nano-Pore Sequencing Technologies
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=3344&type=smp
Which Geographics are Influencing the Growth of the Clinical Oncology Next Generation Sequencing Market?
North America was the largest region in the clinical oncology next-generation sequencing market in 2023. Asia-Pacific was the second largest region in the clinical oncology next-generation sequencing market. The regions covered in the clinical oncology next generation sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Global Clinical Oncology Next Generation Sequencing Market 2025, By The Business Research Company:
Oncology Molecular Diagnostics Global Market Report 2024
RNA Analysis/ Transcriptomics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change
https://www.thebusinessresearchcompany.com/report/human-microbiome-therapeutics-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
